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ABSTRACT
The goal of antibiotic prophylaxis in Odontology is to prevent the onset of infections through the entranceway provided by 
the therapeutic action, therefore it is indicated providing there is a considerable risk of infection, either because of the charac-
teristics of the operation itself or the patient’s local or general condition. Nonetheless, clinical trials with antibiotics in dental 
pathologies have had scant regard for the required methodological criteria and, in addition, are not sufficiently numerous. 
This text presents the results of an expert conference comprising the Presidents of the most representative Scientific Societies 
in Spain who have analyzed the existing literature and have drawn on their valuable professional experience. It describes the 
technical circumstances, analyzes the biological and pharmacological foundations and their application to the most representa-
tive medical situations. It is concluded that antibiotic prophylaxis in Odontology has certain well-founded, precise indications 
and offers the international scientific community a practical protocol for action.
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RESUMEN
La profilaxis antibiótica en Odontología tiene como objetivo prevenir la aparición de infección  a partir de la puerta de entrada 
que produce la actuación terapéutica, por lo que se encuentra indicada siempre que exista un riesgo importante de infección, 
ya sea por las características mismas de la operación o por las condiciones locales o generales del paciente. Sin embargo, los 
ensayos clínicos con antibióticos en patologías dentarias responden poco a los criterios metodológicos requeridos, y además 
no son lo suficientemente numerosos. 
Se presentan los resultados de una conferencia de expertos integrada por los Presidentes de Sociedades científicas  españolas 
más representativas que han analizado la bibliografía existente y han aportado sus valiosas experiencias profesionales. Se 
describen las circunstancias técnicas, se analizan los fundamentos biológicos y farmacológicos y se aplican a las situaciones 
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on professional agreement and consensus documents.
The recommendations proposed in this document are based 




Multi-microbial local infections are cutaneous-mucosa, den-
tal or bone infections that are encouraged following invasive 
dental procedures (2) and they translate clinically into swe-
llings, abscesses, loss of teeth, implants or prosthetic struc-
tures. In a study done in our country, it was demonstrated 
that the complications subsequent to extraction of the third 
molar are an infection and not exclusively inflammatory, 
since statistically significant differences were found in the 
frequency of infectious complications among groups who 
received preventive treatment (5 days) or pre-operative pro-
phylaxis (single dose) with amoxicillin / clavulanate 2000/125 
mg, and the group that received placebo (2.7%, 5.3% and 
16% respectively) (3). Rates of  infectious complication 
were higher in the case of  osteotomy or longer surgical 
duration, treatment being clearly better in these cases than 
prophylaxis or placebo. The infecting innoculant increases as 
the surgical time extends. Thus, the probability of infection 
around dental implants depends basically on how traumatic 
or prolonged the surgery is (4), it being considered that the 
infrequent precocious losses of the implant (5) are due to 
contamination during the insertion phase (6).
Mono-microbial systemic infections are infections that take 
root in patients with infection-susceptible focal point (endo-
cardial alterations, bone or joint prostheses), in patients with 
higher susceptibility to systemic infection by certain micro-
organisms (splenectomized patients or those with infection 
by encapsulated bacteria of the Streptococcus or Haemoph-
ilus genera), or in patients with generalized alterations of the 
immune system that facilitate septicaemia (immunodepres-
sed, immuno-compromised and malnourished). Generally, 
the first step tends to be bacteraemia, which is produced 
after an invasive procedure. This bacteraemia is well studied 
in very prevalent periodontal disease (periodontitis) due 
to the permeability of the epithelium that surrounds the 
tool-tissue interface, and the levels of prostaglandin in the 
local circulation that increase the number of leukocytes and 
fibrinogen levels, slowing down circulation in these cases, 
thus favouring the passage of bacteria to the blood (7). Thus, 
in animal models, endocarditis subsequent to bacteraemia is 
48% in rats with periodontal diseases versus 6% in healthy 
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9. CONCLUSIONS
1. INTRODUCTION
Classically, prophylaxis has been considered pre- or peri-
operative administration of  an antibiotic for prevention 
of a local and/or systemic infectious complication and the 
corresponding clinical consequences.
The aim of antibiotic prophylaxis in surgery is to prevent 
the possible appearance of infection in the surgical wound, 
creating a state of resistance to micro-organisms through 
antibiotic concentrations in blood that avoid bacterial pro-
liferation and dissemination right from the point of entry 
that the surgical wound represents.
10% of antibiotic prescriptions made in our country are used 
for odontogenic infections, and a significant part of them are 
for prophylaxis in dental surgery and procedures (1). Like 
recommendations about use of antibiotics in odontogenic 
infection treatment, antibiotic prophylaxis recommendatio-
ns cannot be based on clinical trials (nor on Evidence-Based 
Medicine), since clinical trials with antibiotics in dental 
pathologies respond little to the required methodological 
criteria, and furthermore are not sufficiently numerous to 
establish a line of conduct. Therefore, the general therapeu-
tic or prophylactic antibiotic prescription strategy is based 
médicas más representativas. Se concluye que la profilaxis antibiótica en Odontología cuenta con indicaciones bien fundamen-
tadas y precisas, ofreciendo a la comunidad científica internacional un protocolo práctico de actuación. 
Palabras clave:  Profilaxis, antibióticos, odontología.
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procedures is around 51-55% (9).
Cost-Benefit balance
The physician’s criterion for choosing antibiotic prophylaxis 
or not must be based on the benefit and the cost of the 
risk. The economic cost of prophylactic operations (usually 
short-term) is acceptable when compared with the total cost 
of dental treatment. Obviously, the benefit is the prevention, 
by the antibiotic, of the infectious complications subsequent 
to surgery and/or procedures. Lastly, the risk of antibiotic 
prophylaxis is the appearance of adverse reactions (funda-
mentally allergic) and the selection of resistances.
Target bacterial population
The target bacterial population depends on the location of 
the infectious complication to be covered. Thus, local infec-
tions following odontogenic procedures are habitually multi-
microbial, since many of the species isolated tend to go in 
pairs (Bacteroides sp and Fusobacterium; Peptostreptococcus 
sp. and Prevotella sp.; Prevotella sp. and Eubacterium sp.) 
(10,11) with a strong aerobic/anaerobic component (12-14), 
and to a much lesser degree, a micro-aerophil component, 
corresponding to the possible contamination/infection 
during surgery by a normal microbiote of the mouth and 
saliva, as well as by odontopathogens of periodontal disease, 
which has very high prevalence (50% of the adult population 
has gingivitis and 30% periodontitis) (15).
The systemic infections to be prevented in patients with 
underlying disease are those subsequent to post-dental ma-
nipulation bacteraemia that generally occur after invasive 
procedures. This bacteraemia is generally mono-microbial, 
and is originated by contamination/infection by a normal 
microbiote or odontopathogen during surgery. We have 
known since the 1930s that, following dental manipulation, 
the number of blood cultures positive for Streptococcus is 
75% in individuals with caries, gingivitis and periodontitis, 
versus 30% in healthy subjects (16,17).
The micro-organisms most frequently involved are Strepto-
coccus of the viridans group, followed by coagulase-negative 
(epidermidis) and coagulase-positive (aureus, and perhaps 
lugdunensis) species of the genus Staphylococcus, of  oral 
origin (18), and lastly in 4-7% of  cases, Gram-negative 
bacilli of the HACEK group (Haemophilus, Actinobacillus, 
Cardiobacterium, Eikenella, Kingella), several of which are 
considered odontopathogens (19). Nor must we forget the 
high percentage of bacteraemias by anaerobes (Eubacte-
rium, Peptostreptococcus, Propionibacterium, Lactobacillus) 
that are detected when the proper methods are used (blood 
cultures for anaerobes) (20,21). Table 1 shows the most 
frequent odontogenic pathogens.
Antibiotic administration regimen
The main goal of antibiotic prophylaxis is to attain elevated 
levels of antibiotic in serum during the surgical process, and 
for some hours after the incision is closed. In this sense, 
the dose used must be high, never lower than that used as 
treatment. Administration prior to surgical intervention 
or the procedure may be sufficient in most interventions. 
Only in those cases in which the half-life of the antibiotic 
is less than one hour and the duration of the intervention 
2-3 hours, or more than twice the half-life of the antibiotic, 
would it be necessary to repeat the dose. Similarly, if  there 
is more than 1-2 L of  blood loss during the procedure, 
administration of an additional dose of antibiotic should 
be considered (22-25).
The patient’s state of health
Invasive oral dental procedures (intraligamentary local 
anaesthesias, endodontia procedures, curettage, placement 
of probes, single and multiple dental extraction, transplants/
re-implants; and periapical, periodontal, bone and implant 
surgery or surgery of the mucosa as well as biopsy of the 
salivary glands, etc.) entail a risk of infection in healthy 
subjects in some cases, and always in individuals at risk for 
local and/or general infection (individuals with transplants, 
implants, immuno-depressed, or suffering from malnourish-
ment or uncontrolled associated pathology, etc.) (2,26).
Non-invasive oral-dental procedures (application of 
fluoride or sealing of fissures, blood-free prosthetic care, 
post-surgical suture removal, orthodontia, radiology and 
non-intraligamentary anaesthesia) do not present risk of 
infection either in healthy subjects or in those at risk, and 
therefore they are never candidates for antibiotic prophylaxis 
(2,26).
In the case of subjects with risk of systemic infection (indi-
viduals with risk of endocarditis and those with joint pros-
theses), prophylaxis will be indicated for invasive procedures, 
and will be true pre-operative prophylaxis (the concept of 
preventive treatment is not applicable in this case) (2,26), 
and generally in a single dose. It is in these latter cases that 
medical and legal implications are discussed most, as legal 
disputes have arisen due to the absence of prophylaxis or due 
to the administration of incorrect antibiotics or at incorrect 
times in the prevention of bacterial endocarditis (27).
Undesirable effects (economic, biological resistance, medical 
and allergic)
Due to the exclusive action of antibiotics on bacterial struc-
tures, the adverse effects are not frequent when compared 
to other types of drug.
AEROBIC N= ANAEROBIC N= 
Streptococcus, viridans group 139 Peptostreptococcus 105
Staphylococcus 9 Prevotella pigmentata 93
Corynebacterium 9 Fusobacterium 90
Campylobacter 9 Prevotella no pigmentata 56
Neisseria 8 Gemella 36
Actinomyces 7 Porphyromonas 35
Lactobacillus 6 Bacteroides 14
Others 13 Others 35 
TOTAL 200 TOTAL 464
Table 1. Pathogen isolates of patients with odontogenic infection.
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AEROBIC N= ANAEROBIC N= 
Streptococcus, viridans group 139 Peptostreptococcus 105
Staphylococcus 9 Prevotella pigmentata 93
Corynebacterium 9 Fusobacterium 90
Campylobacter 9 Prevotella no pigmentata 56
Neisseria 8 Gemella 36
Actinomyces 7 Porphyromonas 35
Lactobacillus 6 Bacteroides 14
Others 13 Others 35 
TOTAL 200 TOTAL 464
Generally speaking, the incidence of  adverse effects of 
antibiotics or idiosyncratic reactions to them is low. This 
allows, e.g. for prophylaxis in situations such as bacterial 
endocarditis in patients with no history of penicillin allergy, 
the use of a single dose of amoxicillin 2 g without fear of 
encountering anaphylactic reactions (28).
Selection of resistance in normal flora (pharyngeal or in-
testinal) depends on the type of antibiotic used, since the 
resistance selection capacity is different for each compound 
(29,30) and less with short periods at high prophylaxis or 
treatment doses (31
Decision making (equational empiricism)
In the last instance, the decision prophylaxis is up to the phy-
sician, who will use the equation: risk = degree of damage x 
probability of suffering it. This approach is subjective. Faced 
with the probability, even remote, of irreparable damages, 
the prevention of systemic infectious complications (for ex. 
infectious endocarditis, late-onset infection of a joint pros-
thesis) must be seen as important by the specialists treating 
them (cardiologists, traumatologists, infectologists, …). 
Given the scarcity of adequate clinical trials, the prevention 
of local complications (for ex. peri-implantitis) as a result 
of dental manipulations will continue to be at the discretion 
of the specialist in question.
3. CLINICAL BASES
The appearance of a continuity solution in the skin, mucosa 
or hard tissues of the mouth consequent to surgical or proce-
dural trauma leads to the alteration of the main barrier that 
stops invasion by micro-organisms. This is how pathogens 
enter and can colonize and infect deep tissues. This means 
that, depending on the bacterial inoculate, the possibility 
of infection increases depending on whether the procedure 
or surgery is clean, clean-contaminated, contaminated or 
dirty. The greater the degree of contamination, the greater 
the risk of post-surgical infection.
The risk of contamination of the surgical field increases 
with exposure time and complexity of the continuity edge 
involved, and is minimized with proper surgical technique 
and the good condition of the patient. However, antibiotic 
prophylaxis has been shown to be a more critical factor and 
a subject for discussion.
The control measures in the surgical technique to minimize 
the risk of infection are: clean incisions; tear-free mucope-
riostial examinations; irrigation as a method for cooling and 
removing drilled alveolar-bone particles; constant aspiration 
and careful haemostasis. If  local anaesthesia is used, avoid 
possible tissue tearing with the needle and ensure slow 
administration of the anaesthesia. Detailed care must also 
be taken with dividers, retractors and tongue depressors 
on the lips, flaps and tissues. If  drains and compression 
dressings have to be put in place, do so in the right posi-
tion. Lastly, we have to remember that some of the sutures 
made bring edges together and there is therefore a transfer 
of both the moist environment of the oral cavity itself  as 
well as food residues, and it is consequently recommended 
that antiseptic or normal saline rinses be started 24 hours 
after the surgery.
As a general rule, prophylaxis is always indicated when 
there is an important risk of infection, either because of the 
characteristics of the operation or because of the patient’s 
local or general conditions. Among the factors that will 
determine the possible appearance of infection are notably 
the type and duration of surgery and the surgical risk of 
the patient due to co-morbidity (assessable in terms of 
anaesthetic risk or ASA class): diabetes, kidney disease, liver 
disease (cirrhosis), cardiopathies and therapeutic immuno-
suppressants (corticoids, radiotherapy, chemotherapy, prior 
infections with antibiotic therapy either not well-known or 
not rationalized). Minor interventions in healthy patients 
do not generally require prophylaxis.
What types of patient require antibiotic prophylaxis?
Using antibiotic prophylaxis or not in dental surgical pro-
cedures and techniques will depend on the type of patient 
and the type of procedure performed. Certain patients are 
candidates for prophylaxis in invasive procedures. And 
in contrast, non-invasive procedures do not require pro-
phylaxis in any case.
To that end, patients could be classified as: a) healthy 
patients, b) patients with local or systemic infection risk 
factors, and c) patients with post-bacteraemia focal infection 
risk factors.
In the healthy individual, prophylaxis is based exclusively 
on the risk of the procedure (26) with transplants, re-im-
plants, grafts, tumour/bone surgery (as with orthopaedic 
and trauma surgery) having a high risk, and also periapical 
surgery and dental inclusions, where the co-existence of 
prior infection is also frequent (2,26).
Patients with local or systemic infection risk factors are 
those that have an increased general susceptibility to 
infections. These are oncological patients, patients with 
congenital or immunological immunodepression (for ex. 
lupus erythematosus), patients with immunodepression 
due to medication (corticotherapy, chemotherapy) after 
transplantation, implant or for any other reason, patients 
with infectious immunodepression (AIDS), patients with 
metabolic disorders (diabetes) and patients with renal or 
hepatic insufficiency (26). There are also splenectomized 
patients who have a higher risk of infection by the genera 
Streptococcus and Haemophilus (32,33).
Patients with post-bacteraemia focal infection risk factors 
are those who present risk of  infectious endocarditis or 
infection of  joint prostheses. With respect to infectious 
endocarditis, 14-20% have an oral origin (9,34). Antibiotics, 
apart from minimizing the prevalence and magnitude of 
bacteraemia (9,35) (they never manage to eliminate it com-
pletely), prevent the bacterial adherence to the endocardium 
(36), which could be the ultimate prophylactic effectiveness 
mechanism. The pathological conditions associated with 
risk of  infectious endocarditis have been defined by the 
American Heart Association (AHA) in the United States, 
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the British Society of Antimicrobial Chemotherapy (BSAC) 
in the United Kingdom and the Agence Française de Sécu-
rité Sanitaire des Produits de Santé (Afssaps)2,37,38 among 
others. With respect to infections of joint prostheses, the 
choice of antibiotic prophylaxis of the dental procedure 
would be based on its devastating morbidity and high mor-
tality (39), and not on the low prevalence of these infections’ 
association with dental procedures (32). Despite this low 
prevalence, prophylaxis is indicated in prostheses implanted 
less than 2 years previously or when there has been prior 
prosthesis infection (2).
Table 2 indicates patients considered at risk.
What dental procedures require antibiotic prophylaxis?
Considering these facts, we need to differentiate between 
invasive oral-dental procedures, those likely to produce 
significant bleeding (Table 3), and non-invasive ones, those 
not likely to produce significant bleeding. Generally, inva-
sive procedures may be considered to be high risk in fragile 
patients.
Surgical wounds were classified by Altemeier in accordance 
with their potential risk of contamination and infection, in 
a classification (40), that time has confirmed as of practical 
utility;
• Type I. Clean wounds (no opening of mucosa such as oral 
cavity): Confirmed infection rate of 1 to 4%. Antibiotic 
prophylaxis not required.
• Type II. Clean-contaminated wounds (opening of mucosa 
such as oral cavity or intervention of inflammatory patho-
logy): Confirmed infection rate of 5 to 15%. These require 
antibiotic prophylaxis with drugs covering Gram positive 
and anaerobic micro-organisms.
• Type III. Contaminated wounds (oncological pathology 
in which there is simultaneous action on the oral cavity and 
the neck): Confirmed infection rate of 16 to 25%. Antibiotic 
prophylaxis must be carried out to cover Gram negative 
organisms whose coverage in clean and clean-contaminated 
surgeries is disputed.
• Type IV. Dirty and infected wounds. Confirmed infection 
rate of above 26%. These always need adequate antibiotic 
treatment.
All the invasive procedures cited in Table 3 are candidates for 
prophylaxis in patients with risk factors for local or system 
infection (patients with immunodepressive factors).
Prophylaxis is always indicated prior to invasive procedures 
performed on patients with post-bacteraemia risk of focal 
infection (endocarditis, prosthetic infection).
In healthy subjects, prophylaxis is only recommended in the 
case of included tooth exodontia, periapical surgery, bone 
surgery, implant surgery, bone grafts and benign tumour 
surgery.
Selection criteria: bacterial target, normal flora, pharmaco-
kinetic and pharmacodynamic aspects and selection of the 
right antibiotic
Antibiotics and the bacterial target of the prophylaxis
The bacteria that cause odontogenic infections are generally 
saprophytes. During evolution of dental caries, the bacteria 
penetrating dentinal tubules are basically opportunistic 
anaerobes such as Streptococcus spp, Staphylococcus spp 
and lactobacilli. When the pulp is necrosed, the bacteria 
advance along the root canal and the process evolves toward 
periapical inflammation. Predominating in this phase are 
Prevotella spp, Porphyromonas spp, Fusobacterium spp 
and Peptostreptococci spp. The microbiology of infectious 
complications is varied: there are many combinations of 
all these organisms, with different characteristics, but both 
anaerobic and aerobic bacteria are habitually present.
Against aerobic or opportunistic Gram positive bacilli in-
volved (Eubacterium, Actinomyces and Propionibacterium) 
and spirochetes, all the groups of antibiotics normally used 
(aminopenicillins, amoxicillin + clavulanate, macrolides, 
lincosamides and metronidazole) are active except for 
metronidazole. Against the Gram positive cocci involved 
(Streptococcus, Staphylococcus and Peptostreptococcus) 
only amoxicillin + clavulanate present adequate coverage 
(2). Against Veillonella, all are active except the macro-
1. INFLAMMATORY ARTHROPATHIES: rheumatoid arthritis, systemic lupus erythematosus 
2. IMMUNOSUPPRESSION due to Disease, Drugs, Transplants or Radiotherapy 
3. DIABETES Mellitus type I 
4. INFECTIOUS ENDOCARDITIS protocols: prior endocarditis, valve prostheses, congenital heart disease, 
surgical bypasses, acquired valve disease, hypertrophic cardiomyopathy, mitral prolapse, sustained murmur and 
Marfan’s syndrome 
5. Osteoarticular prosthesis protocols: less than 2 years after implant and having experienced PRIOR INFECTION 
in the prosthesis. 
6. MALNUTRITION 
7. HAEMOPHILIA 
8. GRAFTS (local factor) 
9. Other associated UNCONTROLLED factors (RENAL or HEPATIC INSUFFICIENCY) and 
SPLENECTOMIZED subjects 
.Table 2. Patients at risk.
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lides (erythromycin, clarithromycin and azithromycin). 
Against the Gram negative bacilli involved (Prevotella, 
Porphyromonas, Fusobacterium, Selenomonas, Eikenella, 
Capnocytophaga, Actinobacillus, Campylobacter rectus 
and Tanerella forsythensis), amoxicillin + clavulanate and 
clindamycin present adequate coverage (except for Eikenella 
corrodens in the case of lincosamide). The high prevalence 
of β-lactamase production in normal or pathologic oral 
anaerobic flora means that without β-lactamase inhibitor 
(clavulanate) amoxicillin is not an adequate antibiotic from 
the physiopathological point of view. Table 4 summarizes 
the activity of the main antibiotics against the most frequent 
odontogenic pathogens (41).
Antibiotics and normal flora
The right antibiotic regime will be the one that acts most 
selectively on the bacteria that may produce complications, 
respecting as much as possible, the usual saprophyte flora.
It is important to consider the ecological aspect when cho-
osing the antibiotic regime to use. Choose the antibiotic and 
the dose (this factor with less importance if the prophylactic 
course is short or of a single dose) that least alters the normal 
saprophyte flora. Taking Escherichia coli as an intestinal flora 
index, macrolides and cetolides are respectful since this micro-
organism is resistant to these compounds. Quinolones, howe-
ver, have selected a high degree of resistance (42), but these 
compounds are not indicated in dentistry. While amoxicillin 
has selected high rates of resistance to E. coli due to produc-
tion of β-lactamase, the sensitivity of amoxicillin combined 
with clavulanate is very high. Where normal flora has been 
studied most extensively, is in the nasopharynx, taking Strep-
tococcus pneumoniae as the index bacteria, a micro-organism 
of the same genus as other species that are prevalent isolates 
in odontogenic infections (viridans group) (43).
PROCEDURE RISK 
USE OF STAPLES FOR ABSOLUTE ISOLATION WITH RUBBER DIKE Low risk 
PERIODONTAL PROPHYLAXIS AND IMPLANTS 




TRUNK ANAESTHESIA TECHNIQUES  
High risk 
Low risk 
EXTRACTIONS High risk 
DENTAL RE-IMPLANTS (Intentional and Traumatic) High risk 
BIOPSIES High risk 
DRAINAGE INCISIONS  High risk 
BONE IMPLANTS High risk 
APPLICATION AND REMOVAL OF SURGICAL SUTURES  Low risk 
RADICULAR SCRAPING AND SMOOTHING 
PERIODONTAL SURGERY  
High risk 
High risk 
IMPLANT INSERTION SURGERY 
MUCOSA-GINGIVAL SURGERY 





ENDODONTIA SURGERY AND APICECTOMY  
Low risk 
High risk 
PROCEDURES FOR AND PLACEMENT OF ORTHODONTIA BANDS 




PLACEMENT OF RETRACTION THREAD 
SCULPTING PROCEDURES WITH BLEEDING 





ORTHOGNATIC SURGERY High risk 
REDUCTION OF MAXILLARY FRACTURES  High risk 
SURGERY ON SALIVARY GLANDS  High risk 
MAXILLO-FACIAL ONCOLOGICAL SURGERY  High risk 
Table 3. Invasive procedures and risk.
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With respect to streptococci, the consumption of antibio-
tics has been reported as the sole cause of resistance in the 
species S. pyogenes and S. pneumoniae, both from a time 
point of view (44,45) and from a geographical standpoint 
(45,47), with resistance to macrolides in these two species 
being connected at the local level (48). While the responsi-
bility of aminopenicillins in the selection of resistances in 
S. pneumoniae is low, the drugs that select most resistances 
to penicillin and macrolides in S. pneumoniae are the oral 
cephalosporins administered twice daily, but they are not 
drugs of choice in dentistry and particularly, macrolides 
administered once or twice a day in S. pneumoniae and 
S. pyogenes. These facts are visible in the species of  the 
viridans group of the genus Streptococcus, where the high 
resistance to macrolides (erythromycin, clarithromycin) (49) 
is frequently associated with high resistance to tetracycli-
nes50 and to clindamycin and azalides (azithromycin) (52). 
Considering that consumption of antibiotics in dentistry 
assumes 10% of the total consumption of antibiotics in the 
community, as mentioned above, it is possible to suspect a 
not unappreciable degree of responsibility in the selection 
of resistances due to antimicrobial treatments in dentistry. 
A high prevalence of oral iatrogenic bacteraemia has been 
described in our country caused by Streptococci resistant to 
erythromycin (40.8%) and clindamycin (21%), the majority 
of the isolates being sensitive to aminopenicillins (52).
Pharmacokinetic and pharmacodynamic aspects
For some antibiotics, the antibiotic concentrations in the 
gingival fluid are similar to or above the serum concentra-
tions, as seen in the case of amoxicillin + clavulanate (53,54), 
spiramycin, metronidazole (55), and quinolones (drugs not 
indicated in the dental field at present). Pharmacodynamic 
coverage is understood as the value of the “relationship 
between the serous pharmacokinetic parameters and in 
vitro susceptibility” predicting for efficacy: a) percentage 
of the dosing interval at which the antibiotic levels surpass 
the MIC (minimum antibiotic concentration that produces 
inhibition of bacterial growth in vitro) that has to be above 
40-50% for β-lactamics, macrolides and lincosamides, and 
b) relationship of the area under the curve of the serous 
levels/MIC that must be above 25 for azalides (azithromy-
cin). Papers have been published that apply these concepts 
in dentistry, analyzing different antibiotics against the five 
most prevalent isolates (but not against all the bacteria 
involved) in odontogenic infections (Streptococcus, group 
viridans, Peptostreptococcus sp., Prevotella intermedia, 
Porphyromonas gingivalis and Fusobacterium nucleatum) 
(43). Only amoxicillin + clavulanate at a dose of 875/125 
mg every 8h or the new formula of 2,000/125 mg every 12h 
as well as clindamycin 3,200 mg every 6-8 h comply with 
the pharmacodynamic requirements (43,56,57), However, 
clindamycin offers worse coverage against oral streptococci 
and adequately for Peptostreptococcus, presenting a not 
unappreciable level of resistances. Metronidazole has no 
activity against aerobic bacteria and macrolides, including 
spiramycin, have a high percentage of resistance to oral 
streptococci and offer very limited activity against Peptos-
treptococcus spp and Fusobcterium nucleatum.
Table 5 shows the recommended doses for prophylaxis with 
different antibiotics.
Selection of the right antibiotic
The antibiotic of choice (if  prophylaxis is considered ne-
cessary because of the type of procedure and patient type) 
must fulfil the following characteristics:
1- Adequate bacterial spectrum, covering all the species 
involved in local multi-microbial infections or distal focal 
mono-microbial infections, including aerobic micro-organis-
ms, micro-aerophils, without forgetting the anaerobes that, 
because of the difficulty in isolating them, are sometimes 
not considered prevalent in oral-origin bacteraemias.
2- Wide clinical spectrum, covering the greatest number of 
dental procedures.
3- Restricted ecological spectrum in order to limit the effects 
on the usual saprophyte flora as much as possible.
4- Adequate pharmacokinetics and pharmacodynamics, 
to allow use in single pre-operative dose in the case of pro-
phylaxis, or wide dosing intervals in preventive, short-term 
treatment, with half-lives or prolonged-release formulas that 
maintain adequate concentrations locally (gingival fluid) 
or systemically (serum) during the entire time the dental 
procedure lasts (prophylaxis).
5- Adequate safety profile, including in paediatric and 
elderly populations.




Peptostreptococcus spp Prevotella spp Porphyromonas spp Fusobacterium spp Oral Streptococci
Penicillin G ± + ± ± + + 
Amoxicillin + + ± ± + + 
Amoxicillin/ 
Clavulanate
+ + + + + + 
Doxicycline + ± ± ± + +
Clindamycin O + + + + + 
Metronidazole O + + + + O 
Macrolides ± ± ± ± ± +
Table 4. Activity of various antimicrobials on periodontal pathogens.
+ More than 80% of strains sensitive; O Less than 30% of strains sensitive; ± 30-80% of strains sensitive.
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odontogenic infections include penicillin, clindamycin, 
erythromycin, cefadroxil, metronidazole and the tetracycli-
nes. These antibiotics are effective against oral streptococci 
and anaerobes. Penicillin V is the penicillin of choice for 
odontogenic infections. It is a bactericide, and although its 
spectrum of action is relatively narrow, it is appropriate for 
odontogenic infection treatments. For the prophylaxis of 
endocarditis associated with dental treatments, amoxicillin is 
the antibiotic of choice (37). Amoxicillin plus clavulanate is 
currently the drug of choice for this group as it has the great 
advantage of keeping its activity against the β-lactamases 
produced commonly by micro-organisms associated with 
odontogenic infections. 
One option, where patients are allergic to penicillins, is clin-
damycin. It is a bacteriostatic, but its bactericide activity is 
obtained clinically with the generally recommended dose. 
The latest macrolides, clarithromycin and azithromycin, 
may also be used if  the patient is allergic to penicillin. Cefa-
droxil cephalosporin can be used when a wider antibacterial 
spectrum of action is needed. Metronidazole tends to be 
used only against anaerobes and is generally reserved for 
situations in which only anaerobic bacteria are suspected. 
Tetracyclines are of  very limited use in dentistry. Since 
tetracyclines can cause changes in the colour of the teeth, 
they should not be prescribed for children under 8, pregnant 
women, or breast-feeding mothers.
Value of antiseptics and oro-dental hygiene
The use of topical antiseptics in the oral cavity reduces the 
bacterial inoculate, but it has not been shown to be effective 
in the prophylaxis of bacterial colonization. However, the 
pre-operative use of antiseptics in the oral cavity can reduce 
complications derived from trauma in the mucosa, especially 
in patients with valve disease, implants of alloplastic ma-
terial, bone grafts, immunodepressed subjects, the elderly 
and in patients with bad oral hygiene.
4. ANALYSIS OF DENTAL PATHOLOGY
Tooth decay is a multi-factorial disease involving, among 
other factors, a wide variety of microbiote; the most fre-
quent bacteria are streptococci of the mutans group, followed 
by the genus Lactobacillus. These bacteria are involved 
in the formation of bacterial plaque, but with a different 
composition depending on the location (58,59).
Bacterial penetration of the tooth occurs without an edge 
being necessary on the outside surface, and is produced 
fundamentally through flakes or cracks, pits and the inter-
prism areas of the enamel, even in normal teeth without 
caries. In cases of incipient enamel caries without cavity, 
bacterial invasion in the deeper layers of the enamel can 
be observed, reaching the dentin amelar limit and even the 
deep dentin layers (60,61), where basically Lactobacillus is 
detected during the initial stages of dentine caries, prior to 
later colonization by Streptococcus and Actinomyces spp.
Streptococci of  the mutans group (S. mutans, S. sobrinus, 
S. cricetus, S. ratius, S. ferus, S. downwi and S. macacae) 
(62) are the most important in the aetiopathogeny of tooth 
decay. Consequently, prescribing antibacterial treatment in 
patients at high risk is advisable for prophylactic purposes 
even when they do not have an evident lesion (63). Chlor-
hexidine, topical fluoride and vancomycin type antibiotics 
are used (to block protein synthesis), as well as iodine- and 
fluorine-based halogenated solutions (63).
The number of bacteria that invade the pulp or the periapi-
cal tissues is directly proportional to the degree of extension 
of the routes for penetration. Bacterial invasion of the pulp 
is always a condition for inflammatory pulp response and 
the seriousness of the process that develops will depend on 
a series of factors such as: the nature of the invasion, the 
microbiote, the number of micro-organisms, the endotoxins, 
the exoenzymes, the metabolites, the exotoxins, the acting 
time and the host’s defensive capability (64).
The bacteria that contaminate pulp tissue can also invade 
Antibiotic Adult dose Paediatric dose†
Amoxicillin 2 g VO 50 mg/Kg VO 
Ampicillin 2 g IM or IV 50 mg/Kg IM or IV 
Amoxicillin + 
Clavulanate
2 g +125 mg VO
2 g + 200 mg IV 
50 + 6,25 mg/Kg VO 
50 + 5 mg/Kg IV 
Cefazolin* 1 g IM or IV 25 mg/kg IM or IV 
Cephalexin or 
cefadroxil* 2 g VO 50 mg/Kg VO 
Clindamycin Clindamycin 600 mg VO Clindamycin 600 mg IV 
Clindamycin 20 mg/Kg VO 
Clindamycin 15 mg/Kg IV 
Clarithromycin and 
azithromycin 
500 mg VO 15 mg/kg VO 
Gentamycin 1,5 mg/Kg IV ( do not exceed 120 mg) 1,5 mg/kg IV 
Metronidazole 1 g IV 15 mg/kg IV 
Vancomycin 1 g IV 20 mg/Kg IV 
Table 5. Initial pre-intervention doses recommended in prophylaxis. 
† The total dose in children should not surpass the adult dose; follow-up doses one-half  the initial dose. * Cephalosporins should not be used in patients 
with type I penicillin hypersensitivity reaction (rash, angioedema or anaphylaxis). VO: orally ; IM: intramuscular; IV: intravenous
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the periapical tissues, but the degree of bacterial invasion 
depends not only on the ability to multiply, but also on the 
motility of the bacteria (64).
Most of the bacteria that originate periapical pathology 
are sensitive, in order of effectiveness, to treatment with 
amoxicillin/clavulanate, ampicillin/sulbactam, clindamycin, 
metronidazole, macrolides, and penicillins (ampicillins, 
amoxicillins).
One of the big problems of endodontal failure is due to the 
persistence of bacterial invasion at the canal or periapical 
level: Actinomyces israelii65 and Enterococcus faecalis.66 
Actinomyces israelli (67) has been observed to be re-
sistant to metronidazole and Enterococcus faecalis 
to clindamycin (68).
5. ANALYSIS OF ORAL AND MAXILLO-FACIAL 
SURGICAL PATHOLOGY
The data in the literature are contradictory, although the 
series seem to indicate that the reduction in post-operative 
complications is due as much to improved surgical technique 
as to rational use of antibiotic prophylaxis. In general terms 
antibiotic therapy pre- and post-operatively is recommended 
in those cases that have a high risk of infection or obvious 
clinical signs of infection.
Surgical interventions can be classified in two large groups, 
depending on the presence or absence of germs in the sur-
gical zone. A series of standard operations in the speciality 
are listed below:
1. Surgery with the presence of germs: undescended teeth; 
exostosis, torus; odontogenic tumours, cysts (uninfected 
epulis, pre-prosthetic and pre-orthodontic surgery; maxi-
llary fractures (closed); glandular affection; osteotomies; 
grafts, flaps, and others.
2. Surgeries in the presence of germs: pericoronaritis of the 
third molar, inflammatory cysts, radicular remains, granu-
lomas, etc.; sialolithiasis, open fractures, traumas, wounds 
with contusions; super-infection added to the tumour lesion, 
radionecrosis and others.
Oral surgery
The infection rate is low, and therefore, in healthy patients 
most oral surgery procedures do not require antibiotic the-
rapy. Prophylactic antibiotic treatment will be used in cases 
of active infection, patients with co-morbidity or who are 
immunocompromised.
Exodontia de wisdom teeth: Some series seem to demonstrate 
that the use of antibiotic therapy post-operatively does not 
improve prognosis in relation to the possibility of post-ope-
rative infection (69,70). However, some authors recommend 
the use of  prophylaxis based on the significant drop in 
post-surgical complications such as pain, trismus, delayed 
scarring of the wound and tumefaction (71-74). In a recent 
randomized, double blind clinical trial of parallel groups the 
efficacy of pre- and post-operative antibiotherapy was com-
pared with placebo. In the study patients were randomized 
to three groups: Placebo group, pre-operative prophylaxis 
group (amoxicillin/clavulanate 2000/125 mg in a single dose 
prior to surgery) and post-operative prophylaxis or preven-
tive treatment group (amoxicillin/clavulanate 2000/125 mg 
every 12 hours for 5 days). The prevalence of post-operative 
infection was significantly higher (p = 0.006) in the group 
of patients treated with placebo (16%) than in the group of 
patients who received amoxicillin/clavulanate 2000/125 mg, 
either as pre-operative (5.3%) or post-operative prophylaxis 
(2.7%). In surgeries that need osteotomy, preventive treat-
ment was better than pre-operative prophylaxis and placebo 
(24%, 9% and 4% respectively) (3).
Implantology. A recent review of the literature on efficacy 
of  antibiotics in preventing complications and failures 
following dental implants concluded that there is no evi-
dence either to recommend or to discourage the use of 
antibiotics for prevention of dental implant complications 
and failures, due to the absence of randomized, controlled 
clinical trials (75).
Gynther et al. compared the efficacy of penicillin V ad-
ministered before and after the surgery against placebo in 
279 patients, without differences being found in relation 
to post-operative infection rate or survival of the implant 
among the two groups (76). Dent et al., in a multi-centric 
study of 2,641 dental implants, found a significantly sma-
ller rate of failures in those that had received pre-operative 
antibiotics in comparison with those who had not. Lastly, 
in a recent study, no greater efficacy was observed with 
the use of post-operative antibiotherapy during 7 days as 
against a single dose during surgery (77). In patients with 
prior radiotherapy, prolonged antibiotherapy regimes are 
used to avoided the presence of osteomyelitis or loss of the 
osteointegrated implant devices. Likewise, based on clinical 
experience, the use of antibiotics would be recommended 
in patients with immunodeficiency, metabolic diseases (like 
diabetes) and risk factors for endocarditis.
Traumatology
Prophylactic antibiotherapy in compound fractures is widely 
accepted.
Mandibular and dentoalveolar fractures: the antibiotic 
treatment plans are the classic ones for other cervical-facial 
pathology (penicillin and derivatives and third-generation 
cephalosporins). Prophylactic antibiotic treatment in un-
complicated fractures does not seem to provide any benefit 
although many professionals do treat these fractures in order 
to cover possible infections and so reduce their incidence. 
Antibiotic treatment in the first 72 hours is not necessary. 
Antibiotic treatment of infectious complications (abscesses, 
pseudoarthrosis, osteomyelitis…) is where there is more 
consensus, although in this case it stops being prophylactic 
antibiotherapy and becomes therapeutic.
Orbital fractures: there is no consensus in the literature 
(some authors defend antibiotic treatment while others 
do not).
Mid and upper third fractures: third-generation cephalospo-
rins are used in those cases where there is liquorrhea.
Orthognatic surgery and pre-prosthetic surgery
Clean-contaminated surgeries, in which some series have 
demonstrated effectiveness of  post-operative antibiotic 
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prophylaxis (penicillin, cephalosporins that do not improve 
prognosis and involve higher cost), although other authors 
appear to demonstrate there is no evidence of better progno-
sis related to infection due to post-operative antibiotherapy, 
especially if  administered orally.
Greater incidence of  infections in bi-maxillary surgery 
without antibiotic treatment has been described.
Some studies have used oral levofloxacin or cefazolin IV 
in mandibular osteotomies, but in this latter case, it is 
better to use amoxicillin-clavulanate for strains resistant 
to cefazolin.
In prior publications, the treatment time had been establis-
hed at 5 days for prophylactic antibiotic coverage, but the 
incidence of post-operative infection is the same in regimens 
of 1 or 5 days, although there is a certain improvement in 
post-operative morbidity by prolonging treatment during 
5 days.
Salivary Glands
No effectiveness with the use of antibiotic prophylaxis has 
been demonstrated in surgeries such as parotidectomy or 
submaxillectomy.
Oncological, reconstructive and cervical surgery.
It has been demonstrated that peri-operative use of antibio-
tics significantly lowers the rate of post-operative infections. 
As in the above cases, in cervical pathology and, fundamen-
tally, in oncological surgery, prophylactic antibiotherapy 
regimens can be used combining clindamycin and cefazolin, 
cephalosporins, aminoglucosides, quinolones or penicillin 
derivatives with betalactamase inhibitors.
The risk of infection arises with the possibility of clean 
areas being put in contact with the oral mucosa, since 
the principal source of contamination in these patients is 
saliva, which transports a large number of bacteria. Other 
contributing factors are a bad general condition, immu-
nosuppression states, radiotherapy or chemotherapy pre-
operatively, reconstruction flaps or those procedures that 
expose tissues to tissue ischemia or necrosis. The sources 
of micro-organisms in these pathologies are saliva, skin, 
teeth and the tumour itself, and therefore the antibiotic of 
choice must cover not just the common micro-organisms 
of saliva, such as Gram positive cocci and anaerobes, but 
also Gram negative organisms that are commonly isolated 
in tumours. A large number of references in the literature 
do not consider that Gram negative micro organisms have 
to be covered in oncological surgery of the head and neck, 
but recent publications do seem to associate better prognosis 
with coverage of Gram negative organisms.
An antibiotherapy guideline may be gentamycin + clin-
damycin, that do well in covering Gram positive, Gram 
negative and anaerobic organisms (not so cefazolin that 
does not cover anaerobes). Amoxicillin-clavulanate and 
ampicillin-sulbactam also have the same spectrum as against 
clindamycin that does not cover anaerobes sufficiently.
The duration of treatment is not standardized and in many 
cases is at the discretion of  the surgeon. Post-operative 
antibiotherapy tends to be maintained until removal of 
drains, although it is prolonged in cases of surgical wound 
infection, dehiscence or fistula.
6. ANALYSIS OF PERIODONTAL PATHOLO-
GY:
Although most rules for antibiotic prophylaxis in perio-
dontia are based on concepts that can be generalized to 
prophylaxis for surgical oral procedures, periodontal in-
fections present particular situations that should be treated 
separately.
What procedures in periodontia require prophylactic treat-
ment with antibiotherapy?
This question could be posed in another way: what proce-
dures in periodontia produce bacteraemias?
All dental procedures that induce bleeding will develop bac-
teraemia that will rarely persist more than 15 minutes (78). 
The following procedures or techniques could be considered 
to fulfil these criteria in Periodontia:
It has been observed that periodontal probing in humans 
causes transitory bacteraemia, confirmed via blood cultu-
res (79,80). Studies in animals have also demonstrated that 
radicular scraping and smoothing techniques can cause it 
(81). In humans, it has been observed that radicular scraping 
and smoothing techniques cause transitory bacteraemia, 
whether these are with curette instruments or ultrasonic 
instruments are used (82,83). Application of chlorhexidine 
0.12% by subgingival irrigation, immediately or during use 
of ultrasonic apparatus or curettes reduces but does not eli-
minate the transitory bacteraemia (82,83). The use of other 
antiseptics such as povidone iodide after periodontal use of 
instruments has not been shown to be effective in reducing 
or eliminating the transitory bacteraemia (84).
Periodontal surgery causes transitory bacteraemia that is 
significantly reduced with the use of antibiotic prophylaxis 
(85). Although the use of  antibiotherapy in periodontal 
surgery procedures is discussed a great deal, post-operative 
infections occur despite the fact that the prevalence of these 
infections is low (86). Transitory bacteraemia also occurs 
with suture removal (87).
The controversy could occur when the evidence of  bac-
teraemias produced by non-invasive manoeuvres such as 
tooth brushing or gum chewing is analyzed (88,89). Table 6 
shows the rate of bacteraemias, comparing dental treatment 
actions and oral hygiene operations (90-92).
Incidence of bacteraemias in relation to dental treatments and oral 
hygiene 
Bacteraemia due to dental treatments  Bacteraemia due to oral hygiene 
Dental extraction 51-85% Tooth brushing 0-26% 
Periodontal surgery 36-88% Flossing 20-58% 
Radicular scraping and smoothing 8-80% Use of dental picks 20-40% 
Periodontal prophylaxis 0-40% Irrigation 7-50% 
Endodontia 0-15% Chewing 17-51% 
Table 6. Incidence of bacteraemias comparing dental treatment actions 
and oral hygiene operations.
Bender IB 1984, Everett ED 1977, Guntheroth WG 1984.
E198
Oral Surgery                                                                                                                                                            � Antibiotic prophilaxis                                                         Oral Surgery Med Oral Patol Oral Cir Bucal 2006;11:E188-205.                                                �         Antibiotic prophilaxis
The question that arises then is, if  bacteraemia-producing 
stimuli occur spontaneously several times a day with no 
type of antibiotic coverage, do other invasive procedures 
related to surgical manipulations have to be done under 
antibiotic coverage?
Although it is said that the extent of the inflammation and 
its seriousness might be related to the magnitude of the 
bacteraemia and it is logical to think this, it has not been 
connected in experiments with the clinical-anatomical-pa-
thological degree of the inflammation.
Histological studies have demonstrated that even under 
normal clinical conditions, a certain tissue alteration is 
always present that would be compatible with a favourable 
environment for bacteraemias (93). Nor has any difference 
been established between gingivitis and periodontitis in the 
production of bacteraemias (94).
Besides, epidemiology studies report that most of the popu-
lation at any age has a certain level of clinical inflammation 
and healthy gums are found in very low percentages of the 
population (95).
7. ANALYSIS OF THE PATHOLOGY IN CHIL-
DREN
Antibiotic prophylaxis in children follows the same princi-
ples as for adults, taking into account only the pharmaco-
kinetic and toxicity peculiarities. In this respect, and by way 
of example, the use of antibiotics such as quinolones is not 
recommended for children. Likewise, tetracyclines should 
not be administered to children less than 8 years of age.
As a starting point, we believe it necessary to define a series 
of distinctive peculiarities regarding antibiotic treatment in 
children: a) in the early stages of life, children do not have 
any medical history leading to suspicion of the presence of 
possible adverse reactions or drug allergies; b) the larger 
proportion of water in children’s tissues, plus the greater 
sponginess of the bone tissues, allow faster dissemination 
of infection on the one hand, and on the other, makes it 
necessary to ensure a proper adjustment of the dose of the 
medication prescribed; c) anaesthetic procedures in milk 
teeth in the process of  rhizolysis can include intraliga-
mentary injections, which however, increase the possibility 
of bacteraemia; and d) the deficient oral hygiene of most 
children and the consumption of  saccharose-rich foods 
contribute to increasing the number of germ colonies in 
the oral cavity, and with this, the risk of bacteraemia after 
oral treatments.
Several studies have assessed the prevalence and extent of 
bacteraemias after different dental procedures in children. 
It was demonstrated that just tooth brushing is associated 
with bacteraemia in more than one in three children (96 
).Conservative dental treatments, in which wedges or matri-
ces are put in, or orthodontic procedures such as placement 
or removal of bands can cause bacteraemia in a significant 
number of children (97). In simple tooth extraction, bac-
teraemia appears in 40-50% of the children examined (96). 
The highest levels of bacteraemia are found after intraliga-
mentary injections in local anaesthesia procedures (96.6% 
of children) (98). Streptococci of  the viridans group were 
isolated in more than 50% of cases.
The level of oral hygiene has a considerable influence on 
levels of bacteraemia. Because of this, optimal oral hygiene 
could be the most important factor in preventing complica-
tions consequent to a bacteraemia; in the opinion of some 
authors, more than any antibiotic course (99).
Dental trauma pathology is an aetiological factor of infec-
tion in the oral area, particularly when there is direct expo-
sure of the pulp tissue and/or alteration of the periodontal 
space. The possibilities of infection will increase when the 
presence of open wounds in skin or mucosa is added to the 
trauma in the hard or support dental tissue.
8. PROPHYLAXIS OF BACTERIAL ENCOCAR-
DITIS
These recommendations are a summary of the agreements 
and consensus documents of the American Academy of 
Cardiology (37), that has since been accepted by most 
scientific and professional societies.
It will be applied in all patients with predisposing heart 
disease who are going to be submitted to a procedure with 
risk of bacteraemia in oral and maxillo-facial surgery. In 
relation to the endocarditis risk, we can classify cardiopa-
thies as (37):
1. High risk: endovascular prosthesis, prior endocarditis, 
complex cyanogenic congenital cardiopathy or systemic-
pulmonary fistulas made surgically.
2.  Moderate risk: other congenital cardiopathies, acquired 
valve disease, mitral prolapse with insufficiency, hypertro-
phic myocardiopathy.
3. Low risk: CIA ostium secundum, operated CIA or CIV, 
prior by-pass, mitral prolapse without regurgitation, pace-
makers, implantable defibrillator.
High and moderate risk patients who are going to have sur-
gery in the maxillo-facial area require antibiotic prophylaxis, 
using 1 hour before by the oral route or 30 minutes before 
intravenously as the antibiotic standards. Table 7 shows the 
antibiotics recommended for children and adults.
In addition, children with a history of IV drug use, and 
certain syndromes (e.g. Down Syndrome, Marfan’s Syndro-
me) can have a risk of bacterial endocarditis because of the 
associated cardiac anomalies.
Although not sustained by scientific evidence, the American 
Academy of Cardiology recommends that “individuals with 
a risk of developing bacterial endocarditis need to maintain 
the best possible oral hygiene”. Other authors have stated 
that “maintaining good oral health, thus reducing daily 
bacteraemias, is probably more important in preventing 
endocarditis than preventive administration of antibiotics 
before specific dental interventions.”
Another aspect that has to be cleared up in the future is 
whether bacteraemias associated with active periodontitis 
are significantly reduced with control of the periodontal 
infection and therefore, if  treatment is a form of prophylaxis 
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effective against endocarditis. Periodontal pathogenic bac-
teria rarely cause endocarditis, although the HACEK group 
of micro-organisms, including Actinobacillus actinomycetem-
comitans and Eikenella corrodens, has increased in importan-
ce in the aetiology, which would sustain the hypothesis of a 
relative increase in the importance of periodontal diseases 
in the aetiology of endocarditis.
9. CONCLUSIONS
1. The aim of antibiotic prophylaxis in surgery is to prevent 
the possible appearance of infection of the surgical wound, 
creating a state of resistance to micro-organisms through 
antibiotic concentrations in blood that avoid the prolifera-
tion and dissemination of bacteria from the point of entry 
represented by the surgical wound.
2. 10% of antibiotic prescriptions are used for odontoge-
nic infections and a significant part of these are used in 
prophylaxis.
3. Clinical trials with antibiotics in dental pathologies 
respond little to the required methodological criteria, and 
furthermore are not sufficiently numerous.
4. As a general rule, prophylaxis is always indicated when 
there is an important risk of infection, either because of the 
characteristics of the operation or due to the patient’s local 
or general conditions.
5. The risk of contamination of the surgical field increases 
with the time of exposure and the complexity of the trauma 
produced and is minimized with adequate surgical techni-
que and with the good condition of the patient. However, 
antibiotic prophylaxis has been shown to be a more critical 
factor and a subject for discussion.
6. In a study done in our country, it was demonstrated that 
the complications subsequent to extraction of  the third 
molar are an infection and not exclusively inflammatory, 
since statistically significant differences were found in the 
frequency of infectious complications among groups who 
received preventive treatment (5 days) or pre-operative 
prophylaxis (single dose) and placebo (2.7%, 5.3% and 16% 
respectively). Rates of infectious complication were higher 
in the case of osteotomy or longer surgical duration.
7. Local multi-microbial infections are cutaneous-mucosa 
or bone infections that occur consequent to invasive dental 
procedures.
8. Mono-microbial systemic infections are infections that 
take root in patients with a focus susceptible to infection 
(endocardial changes, bone or joint prostheses), in patients 
with greater susceptibility.
9. The physician’s criterion for choosing antibiotic pro-
phylaxis or not must be based on the benefit and the cost 
of the risk. In the last instance, the prophylaxis decision is 
the choice of the physician, who will use the equation: risk 
= degree of damage x probability of experiencing it. This 
approach is subjective.
10. To that aim, patients could be classified as: a) healthy 
patients, b) patients with local or systemic infection risk 
factors, and c) patients with post-bacteraemia focal infec-
tion risk factors. In healthy subjects, prophylaxis is based 
exclusively on the risk of the procedure.
11. The antibiotic of choice (if  prophylaxis is considered 
necessary because of  the type of  procedure and patient 
type) must fulfil the following characteristics:
• Adequate bacterial spectrum, covering all the species 
involved in local multi-microbial infections or distal focal 
mono-microbial infections, including aerobic micro-organis-
ms, micro-aerophils, without forgetting the anaerobes that, 
because of the difficulty in isolating them, are sometimes 
not considered prevalent in oral-origin bacteraemias.
• Wide clinical spectrum, to cover the greatest number of 
dental procedures.
• Restricted ecological spectrum in order to limit the effects 
Prophylaxis Adults Children†
Standard Amoxicillin 2 g VO or IV Amoxicillin 50 mg/kg VO. (maximum 2 g). 
Clindamycin 600 mg VO Clindamycin 20 mg/kg VO. (Maximum 
600 mg)
Azithromycin 500 mg VO Azithromycin 15 mg/kg VO 
Allergic to 
betalactames 
Clarithromycin 500 mg VO Clarithromycin 15 mg/kg VO 
Oral intolerance Ampicillin 2 g mg IM or IV Ampicillin 50 mg/kg IM or IV 
Cefazolin 1 g IM or IV* Cefazolin 25 mg/kg IM or IV (maximum 1 
g)*Oral intolerance and 
penicillin allergy  
Clindamycin 600 mg IV Clindamycin 15 mg/kg IV. OR IV. (Maximum 600 mg). 
Table 7. Endocarditis prophylaxis recommendations.
† The total dose in children should not surpass the adult dose; follow-up doses one-half  the initial dose.
* Cephalosporins should not be used in patients with type I penicillin hypersensitivity reaction (rash, angioedema or anaphylaxis).
VO: orally ; IM: intramuscular; IV: intravenous.
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on the usual saprophyte flora as much as possible.
• Adequate pharmacokinetics and pharmacodynamics, to 
allow use in single pre-operative dose in the case of pro-
phylaxis, or wide dosing intervals in preventive, short-term 
treatment, with half-lives or prolonged-release formulae that 
maintain adequate concentrations locally (gingival fluid) 
or systemically (serum) during the entire time the dental 
procedure lasts (prophylaxis).
•  Adequate safety profile, including in paediatric and elderly 
populations.
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Procedure Prophylaxis in patient at risk 
(YES/NO) 
Prophylaxis in healthy 
patient (YES/NO) 
Antibiotic and regime (pre-intervention dose) 
 
Use of staples for absolute isolation with rubber dikes 
YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Periodontal prophylaxis and implants YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Periodontal probing YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Periodontal maintenance YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Intraligamentous anaesthesia 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Trunk anaesthesia techniques  
YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Extractions 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Dental re-implants  (intentional and traumatic) 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Biopsies 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Drainage incisions 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Bone implants 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Application and removal of surgical sutures 
YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Table 8. Antibiotic prophylaxis in different procedures.
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Table 8. (cont.)
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Radicular scraping and smoothing  
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Periodontal surgery 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Implant insertion surgery 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Mucosa-gingival surgery 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Removal of implant posts 
YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Endodontia 
YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Endodontia surgery and apicectomy 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Procedures for and placement of wedges, moulds, 
orthodontia bands abd pre-formed crowns YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Placement of removable orthodontia apparatus  
NO NO 
 
Taking impressions YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Placement of retraction thread  YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Sculpting procedures with bleeding YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
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Pre-prosthetic surgery YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Orthognatic surgery 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Dental and alveolo-dental trauma 
YES NO 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Reduction of maxillary fractures 
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Surgery on salivary glands  
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
Maxillo-facial oncological surgery  
YES YES 
Amoxicillin + Clavulanic Acid 
Adults: 2gr+125gr V.O. / 2gr+200gr  I.V. 
Children: 50mgr +6.25 mgr/Kg V.O./ 50mgr+5mgr/Kg I.V. 
Clindamycin 
Adults: 600mgr V.O. / 600mgr I.V. 
Children: 20 mgr/kg V.O. / 15mgr/kg I.V. 
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